EP2178513
Samsetningar í töfluformi sem innihalda atasanavir.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.6.2008EP published:
30.3.2011EP application number:
08771569.4
EP translation filed:
20.4.2011Grant published:
15.5.2011EPO information:
European Patent Register
Max expiry date:
19.6.2028Expiry date:
19.6.2019
Title:
TABLETED COMPOSITIONS CONTAINING ATAZANAVIR
Timeline
Today
20.6.2008EP application
30.3.2011EP Publication
20.4.2011Translation submitted
15.5.2011Registration published
19.6.2019Expires
Owner
Name:
Bristol-Myers Squibb Holdings IrelandAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
KOO, Otilia May YueAddress:
New Brunswick, New Jersey, US
Name:
NIKFAR, FaranakAddress:
New Brunswick, New Jersey, US
Name:
DIAZ, StevenAddress:
Martinsville, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
945694 PDate:
22.6.2007Country:
US
Classification
Categories:
A61K 9/20, A61K 31/551, A61K 45/06, C07D 213/42
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 4.5.2011
Expires: 20.6.2012
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 7.5.2012
Expires: 20.6.2013
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 8.5.2013
Expires: 20.6.2014
Payer: Árnason Faktor
Number: 7
Paid: 7.5.2014
Expires: 20.6.2015
Payer: Árnason Faktor
Number: 8
Paid: 7.5.2015
Expires: 19.6.2016
Payer: Árnason Faktor
Number: 9
Paid: 10.5.2016
Expires: 19.6.2017
Payer: Árnason Faktor
Number: 10
Paid: 8.5.2017
Expires: 19.6.2018
Payer: Árnason Faktor
Number: 11
Paid: 14.5.2018
Expires: 19.6.2019
Payer: Árnason Faktor